Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity - Schedule of Stock Option Activity (Details)

v3.23.1
Stockholders’ Equity - Schedule of Stock Option Activity (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2023
USD ($)
$ / shares
shares
Stock Options  
Outstanding, beginning balance (in shares) | shares 1,398,286
Granted (in shares) | shares 111,107
Outstanding, ending balance (in shares) | shares 1,509,393
Exercisable at ending (in shares) | shares 1,134,204
Vested and expected to vest at ending (in shares) | shares 1,509,393
Weighted-average Exercise price per share  
Outstanding, beginning balance (in dollars per share) | $ / shares $ 8.69
Granted (in dollars per share) | $ / shares 8.10
Outstanding, ending balance (in dollars per share) | $ / shares 8.65
Exercisable at ending (in usd per share) | $ / shares 8.12
Vested and expected to vest (in usd per share) | $ / shares $ 8.65
Weighted-average Remaining Contractual Life (in years)  
Remaining Weighted-Average Recognition Period (in years) 6 years 2 months 1 day
Exercisable at ending (in years) 5 years 2 months 23 days
Vested and expected to vest (in years) 6 years 2 months 1 day
Intrinsic value, outstanding | $ $ 5,336
Intrinsic value, exercisable | $ 5,087
Intrinsic value, vested and expected to vest | $ $ 5,336